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Abstract
Background: The APOA5 gene variants, -1131T>C and S19W, are associated with altered triglyceride concentrations
in studies of subjects of Caucasian and East Asian descent. There are few studies of these variants in South Asians. We
investigated whether the two APOA5 variants also show similar association with various lipid parameters in Indian
population as in the UK white subjects.
Methods: We genotyped 557 Indian adults from Pune, India, and 237 UK white adults for -1131T>C and S19W variants
in the APOA5 gene, compared their allelic and genotype frequency and determined their association with fasting serum
triglycerides, total cholesterol, HDL and LDL cholesterol levels using univariate general linear analysis. APOC3 SstI
polymorphism was also analyzed in 175 Pune Indian subjects for analysis of linkage disequilibrium with the APOA5 variants.
Results: The APOA5 -1131C allele was more prevalent in Indians from Pune (Pune Indians) compared to UK white
subjects (allele frequency 20% vs. 4%, p = 0.00001), whereas the 19W allele was less prevalent (3% vs. 6% p = 0.0015).
Patterns of linkage disequilibrium between the two variants were similar between the two populations and confirmed
that they occur on two different haplotypes. In Pune Indians, the presence of -1131C allele and the 19W allele was
associated with a 19% and 15% increase respectively in triglyceride concentrations although only -1131C was significant
(p = 0.0003). This effect size was similar to that seen in the UK white subjects. Analysis of the APOC3 SstI polymorphism
in 175 Pune Indian subjects showed that this variant is not in appreciable linkage disequilibrium with the APOA5 -1131T>C
variant (r2 = 0.07).
Conclusion: This is the first study to look at the role of APOA5 in Asian Indian subjects that reside in India. The -1131C
allele is more prevalent and the 19W allele is less prevalent in Pune Indians compared to UK Caucasians. We confirm
that the APOA5 variants are associated with triglyceride levels independent of ethnicity and that this association is similar
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in magnitude in Asian Indians and Caucasians. The -1131C allele is present in 36% of the Pune Indian population making
it a powerful marker for looking at the role of elevated triglycerides in important conditions such as pancreatitis, diabetes
and coronary heart disease.
Background
The APOA5 gene was first identified as a conserved DNA
sequence 27 Kb proximal to the Apolipoprotein cluster of
APOA1, APOA4 and APOC3 on chromosome 11q23 [1].
It is an important regulator of triglycerides, as established
by both genetic manipulation in animals [1] and a large
number of genetic studies in man [1-8]. To date, most
studies of the APOA5 gene have been conducted in
cohorts of Caucasian subjects and have shown that two
haplotypes, defined by the SNPs -1131T>C and S19W, are
independently associated with triglyceride concentra-
tions. The association between -1131T>C and triglyceride
concentrations is likely to be explained by linkage dise-
quilibrium (LD) with SNPs in the neighbouring APOC3
gene whilst there is no LD between S19W and APOC3 var-
iants [9]. Supporting this, the -1131C allele is associated
with lower APOA5 concentrations and higher triglyceride
concentrations whereas the 19W allele is associated with
higher APOA5 and higher triglyceride concentrations, rel-
ative to subjects homozygous for the less common allele
[10,11]. The majority of published reports have observed
the minor allele frequency for both these variants to be
approximately 6% in Caucasian populations [1-8]. How-
ever, the frequencies vary considerably across different
ethnic groups. The prevalence of -1131C allele varies
between 6.4% in American Caucasian males [5] and 34%
in the Japanese population [12], whilst the 19W allele fre-
quency varies between 0.1% in a Chinese population [13]
and 15.8% in Hispanic males [5]. The reported size of
effect of the less common alleles on triglyceride concen-
tration varies in different cohorts from different races
[2,5,12-15]. However, most studies show a 15–30%
increase in triglyceride concentrations with the inherit-
ance of the minor allele at these polymorphisms and there
is no clear evidence that ethnic origin determines the size
of the increase.
There is limited data available on the APOA5 gene variants
in the Asian Indian population. The only study to date is
on Asian Indians residing in Singapore and shows a minor
allele frequency of 23% at -1131T>C and <3% for the
S19W polymorphisms [13]. No study has been conducted
on the role of APOA5 in Asian Indians residing in India. It
is important to understand the genetic contribution to
triglyceride metabolism in Asian Indians since they have
higher triglyceride concentrations compared to Cauca-
sians relative to their BMI and these differences can occur
as early as 10 years old [16].
In this study, we have compared the allele frequency of
the -1131T>C and S19W variants in Pune Indians and UK
white subjects and examined the size of their effect on
fasting triglycerides and other lipid parameters in these
two populations.
Methods
Subjects
The Asian Indian adult cohort comprised of 557 parents
from the Pune children study, which is a consecutive birth
cohort from KEM Hospital, Pune [17]. This cohort con-
sisted of subjects of Indo European descent from Mahar-
ashtra in Western India. The Institutional Ethics
Committee approved the study following the Indian
Council of Medical Research guidelines for research on
human subjects. All subjects gave written informed con-
sent to participate in the study. The UK white adult cohort
included 237 parents from the Plymouth EarlyBird study,
which is a non-intervention prospective study of school
age children and their parents [18]. This cohort complies
with the Declaration of Helsinki, and Local Research Eth-
ics Committee approval was obtained early in 1999. Sub-
jects with diabetes on fasting and 2-hour OGTT criteria
were excluded. Clinical details of subjects are given in
table 1.
Genotyping APOA5 and APOC3 variants
The UK white subjects were genotyped for -1131T>C pol-
ymorphism using the RFLP assay with 2 U of MseI (New
England Biolabs, UK), as previously described [7] while,
genotyping of Pune Indian individuals was performed
using a tetra-primer based PCR method, previously
described [19]. Both the cohorts were genotyped for S19W
using an RFLP protocol with 7 U of EagI, as previously
described [7]. The results of tetra primer assay for -
1131T>C were validated by RFLP analysis in ~10% (50/
524) of randomly chosen Pune Indian samples. In an
attempt to investigate the extent of LD between the
APOA5 -1131T>C and the APOC3 SstI variants, we geno-
typed the APOC3 SstI SNP in 175 Pune Indians by RFLP
assay using 10 U of SstI [7] and validated the results in
~15% (30/175) samples by sequencing.
Quality control measures
Two independent individuals scored the agarose gels to
determine the genotype and any discrepancies were
resolved by sequencing. Rare homozygotes were con-
firmed by re-genotyping and 10% of randomly selected
samples were re-genotyped with a genotyping accuracy of
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>99% for all the variants. Overall, genotypes were
obtained for all the UK white adult samples and 94% (n =
524) of Pune Indian adults.
Statistics
Allele and genotype frequencies were calculated for both
SNPs using chi-squared analyses. Hardy-Weinberg Equi-
librium (HWE) was tested by comparing the observed
with the expected genotype frequency using Chi-square
analysis. The LDMAX function of GOLD software was
used to calculate the linkage disequilibrium between the
two SNPs in APOA5 gene and between the APOA5 -
1131T>C SNP and APOC3 SstI variant. Association analy-
sis between the genotype and various lipid parameters
was performed using univariate general linear model
analysis in SPSS (SPSS 11.0). Continuous parameters were
log transformed where necessary before conducting any
analysis. Genotypes were tested for association with
potential covariates of triglyceride concentrations and if
significantly associated, genotype-triglyceride compari-
sons were adjusted. Since the homozygotes for the less
common allele were rare (<0.05) for both the APOA5 pol-
ymorphisms, the heterozygotes and the less common
allele homozygotes were pooled for further analysis:
((TC+CC) and (SW+WW)). The independent T-Test was
used to determine the standardized effect of these variants
on triglyceride concentrations with the presence or
absence of the less common allele. Regression analysis
was performed to determine the independent effect of dif-
ferent variables on triglyceride concentrations. Although
statistical tests used logged variables where necessary, we
present untransformed means for consistency with previ-
ous studies.
Results and discussion
We present the first study investigating the common
APOA5 variants and their association with lipid concen-
trations in Asian Indian adults, residing in Pune, India, as
compared to UK white adults.
Ethnic differences in the allele frequency of the -1131T>C 
and the S19W polymorphisms
A total of 761 individuals comprising 524 Pune Indian
adults and 237 UK white adults were successfully geno-
typed for the -1131T>C and S19W polymorphisms in the
APOA5 gene. The less common allele at -1131T>C variant
was significantly more prevalent than the S19W polymor-
phism in the Pune Indians (20% vs. 3% respectively),
whereas the allele frequency for both SNPs was compara-
ble in UK white subjects (4% and 6% respectively: table
2). We observed a marked difference in the minor allele
frequency at both SNPs between the Pune Indians and UK
white subjects (table 2). The -1131C allele is more preva-
lent in the Pune Indian subjects compared to the UK white
subjects (allele frequency 20% vs. 4%, p = 0.00001), while
the 19W allele is less prevalent in the Pune Indians (allele
frequency 3% vs. 6% p = 0.0015). Approximately, 1/3rd
(36%) of Indian subjects carried at least one copy of the
less common allele at -1131T>C compared to only 8% of
UK white individuals but only 5% of Pune Indian individ-
uals carry the 19W allele compared to 11% UK white sub-
jects.
The allele frequencies in Pune Indians are consistent with
the only previous study of individuals of Indian descent
from Singapore (23% for 1131C allele and <3% for 19W
allele) [13]. This follows a similar pattern in other Asian
ethnic groups such as Japanese, Malaysian and Chinese
which also have a higher prevalence of the -1131C allele
[13] in contrast to Caucasian populations where the two
variants have similar minor allele frequencies [5].
Linkage disequilibrium analysis did not show association
between the two variants in either of the cohorts (r2 =
Table 1: Clinical characteristics of Pune Indian individuals and UK white subjects.
Pune Indians UK Whites
N 557 237
% male 45 52
Age (Yrs) 36 (32–40) 34 (31–38)
BMI (kg/m2) 22.3 (19.7–24.9) 26 (23.2–28.6)
Total Cholesterol (mg/dl) 155 (133 – 184) 187 (168 – 215)
HDL-Cholesterol (mg/dl) 40 (32 – 49) 53 (46 – 64)
LDL-Cholesterol (mg/dl) 94 (77 – 118) 113 (93 – 139)
Triglycerides (mg/dl) 85 (59 – 119) 84 (62 – 117)
Fasting glucose (mg/dl) 88 (80–96) 85 (79–88)
Fasting insulin (mg/dl) 34 (22–50) 53 (42–75)
Pune Indian individuals (adults from the Pune Children Study) and UK white subjects (adults from the Plymouth EarlyBird study).
Data presented as median (interquartile range); BMI; Body Mass Index, HDL; High Density Lipoprotein, LDL; Low Density Lipoprotein.
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0.005; in Pune Indians and r2 = 0.007 in UK whites), indi-
cating that the two variants fall on different haplotypes in
Indians as they do in other populations.
Effect of the APOA5 variants on triglyceride 
concentrations and other lipid parameters in the Pune 
Indian and UK white subjects
The effect of each APOA5 polymorphism in each group of
subjects is shown in table 3. The presence of the -1131C
allele (TC and CC subjects combined) is associated with
higher triglyceride concentrations in the Pune Indians by
0.25 standard deviations (95% CI, 0.12–0.39; p = 0.0003)
and in the Plymouth EarlyBird study UK whites by 0.5
standard deviations (95% CI, 0.11–0.89; p = 0.01) relative
to TT subjects. The difference in size effect between the
two groups of subjects is not significant.
The presence of the 19W allele was associated with raised
triglyceride concentrations in the Pune Indians by 0.25
standard deviations (95% CI, -0.11–0.60; p = 0.17),
although this did not reach significance, and in the Ply-
mouth EarlyBird study UK whites by 0.41 standard devia-
tions (95% CI, 0.10–0.73; p = 0.008). The 15–19%
increase in the fasting triglyceride concentration associ-
ated with the inheritance of less common alleles at either
of the two polymorphisms in the Pune Indians is a very
similar effect size to that seen in previous studies of Cau-
casian subjects. This suggests that the main difference
between Pune Indians and UK whites is the allele fre-
quency rather than how much they alter the triglyceride
concentration. We also performed all analyses whilst cor-
recting for age and sex but the p values and effect sizes
changed very little because genotypes were not associated
with age or sex. There were no associations between the
two APOA5 variants and either HDL, LDL or total choles-
terol in either the Pune Indian or UK white subjects,
although this may be due to lack of power if the effects on
these lipid parameters is less than the effects on triglycer-
ides.
We next assessed the extent of linkage disequilibrium
between the APOA5 -1131T>C SNP and the APOC3 SstI
SNP in Pune Indians and observed D' and r2 values
between these two SNPs of 0.41 and 0.07 respectively.
This suggests that the highly significant association
between the APOA5 -1131T>C variant and triglyceride
concentrations is not driven by LD with the APOC3 SstI
SNP. Further work is needed to assess more comprehen-
Table 3: Association of serum triglyceride concentrations and other lipid parameters (mg/dl) with APOA5 genotype for -1131T>C and 
S19W.
-1131T>C S19W
TT CT CC Effect on lipid (SD)* P Value SS SW+WW Effect on lipid (SD) P Value
Triglycerides Pune Indians 91.5 (3.1) 110.1 (4.3) 106.0 (13.1) 0.25 (0.12, 0.39) 0.0003 97.2 (2.5) 114.0 (11.0) 0.25 (-0.11, 0.60) 0.17
UK whites 95.3 (3.8) 125.3 (12.6) - 0.50 (0.11, 0.89) 0.01 94.4 (3.7) 123.0 (12.1) 0.41 (0.10, 0.73) 0.008
HDL Pune Indians 41.4 (0.7) 41.2 (0.9) 37.2 (2.9) -0.03 (-0.21, 0.15) 0.73 41.1 (0.6) 41.7 (2.4) 0.07 (-0.32, 0.47) 0.71
UK whites 55.8 (0.95) 54.2 (2.3) - -0.03 (-0.49, 0.44) 0.91 56.1 (0.96) 51.9 (2.5) -0.33 (-0.72, 0.07) 0.10
LDL Pune Indians 96.8 (1.8) 101.6 (2.5) 100.1 (7.6) 0.11 (-0.08, 0.29) 0.25 98.2 (1.5) 103.5 (6.3) 0.16 (-0.24, 0.56) 0.44
UK whites 115.5 (2.4) 123.9 (5.5) - 0.26 (-0.21, 0.73) 0.27 115.5 (2.3) 121.1 (8.3) 0.05 (-0.35, 0.46) 0.79
Total Cholesterol Pune Indians 156.6 (2.0) 164.6 (2.7) 158.6 (8.5) 0.19 (0.01, 0.36) 0.04 158.8 (1.6) 167.9 (7.1) 0.25 (-0.15, 0.64) 0.22
UK whites 189.8 (2.5) 202.6 (5.4) - 0.36 (-0.11, 0.83) 0.13 190.0 (2.5) 197.1 (8.6) 0.13 (-0.27–0.53) 0.52
Values are given as mean (SE), units (mg/dl); P values are based on linear regression analysis. SD = standard deviations. *Effect on triglycerides in 
Pune Indians is for CC+CT individuals versus TT individuals and for both studies are based on logged values. There are no -1131CC individuals in 
the UK white population.
Table 2: Prevalence of APOA5 gene variants -1131T>C and S19W in Asian Indians and UK white subjects.
SNP -1131T>C S19W
TT TC CC Carrier* Frequency (95% CIs) Less common allele 
Frequency (95% CIs)
SS SW WW Carrier* Frequency 
(95% CIs)
Less common allele 
Frequency (95% CIs)
Pune Indians (n = 524) 336 170 18 0.36 (0.32–0.40) 0.20 (0.17–0.22) 497 27 0 0.05 (0.03–0.07) 0.03 (0.02–0.04)
UK whites (n = 237) 218 19 0 0.08 (0.05–0.11) 0.04 (0.02–0.06) 210 26 1 0.11 (0.07–0.15) 0.06 (0.04–0.08)
P value <0.00001 0.0015
Asian Indians (adults from the Pune Children Study) and UK white subjects (adults from the Plymouth EarlyBird study).
P values are calculated for differences in genotype frequencies between Pune Indians and UK white subjects. *Carrier frequency indicates individuals 
carrying at least one copy of the less common allele at either polymorphism. Neither population showed any deviation from HWE for either 
polymorphism (p > 0.05).
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sively the role of other common variations in the APOC3
gene in Indian subjects.
Comparison of associations between genotype and 
phenotype variables on triglyceride concentrations in the 
Pune Indians and the UK white subjects
Regression analysis to determine the effect of different var-
iables on triglycerides concentrations is shown in table 4.
Except for the S19W variant, all the variables including
age, sex, BMI, fasting glucose and insulin and -1131T>C
were significantly associated with triglyceride concentra-
tions in the Pune Indian individuals. Sex and BMI were
most strongly correlated with triglyceride concentrations
in the Pune Indians (r2 = 0.13 and r2 = 0.12 respectively, p
< 0.001) whilst sex, BMI and fasting insulin were all
strongly correlated with triglyceride concentrations in the
UK whites (r2 = 0.12, r2 = 0.14 and r2 = 0.16 respectively, p
< 0.001). In both cohorts, the APOA5 alleles are associ-
ated with variation in triglyceride concentrations.
Conclusion
We conclude that the -1131C allele in APOA5 is consider-
ably more common in Indo Europeans from Maharashtra
(Pune Indians) than in UK white subjects and has a simi-
lar impact on triglyceride concentration. Conditions asso-
ciated with hypertriglyceridaemia, such as pancreatitis,
insulin resistance, type 2 diabetes and coronary heart dis-
ease are highly prevalent in Asian Indian populations. The
relatively high -1131C allele frequency within Pune
Indian subjects will mean it is possible to assess whether
a life-long increase in triglyceride concentrations as a
result of inheriting this variant increases the risk of these
disorders [20].
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